You have 9 free searches left this month | for more free features.

IGF1R

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung

Completed
  • Non Small Cell Lung Cancer
  • Protein expression by immunohistochemistry and immunofluorescence
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Blood sample collection
  • Mansoura, Dakahliya, Egypt
  • +1 more
Apr 5, 2022

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

Recruiting
  • Breast Cancer Female
  • +7 more
  • DC1 Vaccine
  • WOKVAC Vaccine
  • Tampa, Florida
  • +6 more
Apr 4, 2022

Malignant Glioma, Tumors Trial in Philadelphia (IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion

Completed
  • Malignant Glioma
  • Neoplasms
  • IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours.
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Oct 5, 2020

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Molecular Imaging Trial in Harbin (68Ga-NODAGA-ZIGF-1R:4:40)

Unknown status
  • Molecular Imaging
  • 68Ga-NODAGA-ZIGF-1R:4:40
  • Harbin, Heilongjiang, China
    TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
Feb 20, 2020

The AgRP and GH/IGF-1 Axis in Children

Not yet recruiting
  • Growth Hormone Deficiency
    • (no location specified)
    Dec 8, 2022

    Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)

    Not yet recruiting
    • Acute Kidney Injury (Nontraumatic)
    • Pneumoperitoneum
    • IGF-1
    • (no location specified)
    Nov 8, 2022

    Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

    Not yet recruiting
    • Glioblastoma Multiforme
    • Glioblastoma
    • IGV-001 Cell Immunotherapy
    • +3 more
    • Newark, Delaware
    • +22 more
    Jun 24, 2022

    Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low

    Recruiting
    • Growth Retardation
    • (enteral feeding volume/ total fluid volume)*100%
    • Xingtai, He Bei, China
      Wei Guo
    Oct 4, 2023

    Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)

    Recruiting
    • Insulin Growth Factor I Deficiency
    • +2 more
    • HIIT
    • +2 more
    • Seville, Spain
      Education Faculty
    Nov 30, 2022

    Sarcopenia, Geriatric, Muscle Mass Trial in Palembang (Ophiochepalus striatus extract, Placebo)

    Recruiting
    • Sarcopenia
    • +4 more
    • Ophiochepalus striatus extract
    • Placebo
    • Palembang, South Sumatera, Indonesia
      Mohammad Hoesin Central General Hospital
    May 11, 2023

    Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

    Not yet recruiting
    • Thyroid Eye Disease
    • VRDN-001 10 mg/kg Drug:
    • (no location specified)
    Sep 7, 2023

    IGF1 Deficiency Trial in Worldwide (Increlex®)

    Recruiting
    • IGF1 Deficiency
    • Miami, Florida
    • +50 more
    Dec 29, 2022

    22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)

    Completed
    • 22q13 Deletion Syndrome
    • Phelan-McDermid Syndrome
    • Insulin-Like Growth Factor-1 (IGF-1)
    • Normal saline
    • New York, New York
      Seaver Austin Center, Icahn School of Medicine at Mount Sinai
    Apr 18, 2022

    Failure to Thrive, Infection, Bacterial, Growth Faltering Trial in Surabaya (high calorie formula (oral nutritional

    Recruiting
    • Failure to Thrive
    • +2 more
    • high calorie formula (oral nutritional supplement/ONS)
    • Surabaya, East Java, Indonesia
      Husada Utama Hospital
    Oct 2, 2022

    Short Stature Trial (Increlex)

    Active, not recruiting
    • Short Stature
    • (no location specified)
    Oct 14, 2022

    Relation Between Serum IGF-1 & BMI In Acne Vulgaris

    Not yet recruiting
    • Evaluation of Serum Level of Insulin Like Growth Factor 1
      • (no location specified)
      Aug 16, 2022

      Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)

      Completed
      • Breast Cancer
      • +7 more
      • IGF-Methotrexate conjugate
      • Chicago, Illinois
        University of Illinois at Chicago
      Aug 20, 2019

      Recovery in Post-stroke Rehabilitation

      Completed
      • Ischemic Stroke
        • Lodz, Poland
          Medical University of Lodz
        Feb 20, 2023

        Cancer, Overweight and Obesity Trial (Aerobic Exercise)

        Not yet recruiting
        • Cancer
        • Overweight and Obesity
        • Aerobic Exercise
        • (no location specified)
        Dec 13, 2022